肺癌生物标志物的研究现状与资金投入趋势。
Research status and funding trends of lung cancer biomarkers.
机构信息
Department of Health Science, National Natural Science Fundation of China, Beijing 100083, China.
出版信息
J Thorac Dis. 2013 Oct;5(5):698-705. doi: 10.3978/j.issn.2072-1439.2013.10.10.
Abstract
Lung cancer is one of malignant tumors with the highest morbidity and mortality in the world. At present, research of early diagnosis, treatment, prognosis, and metastasis associated biomarkers is most active. This article reviewed the research status of lung cancer biomarkers and analyzed the funding situation in the field of lung cancer markers in recent 10 years in China and abroad, to provide a reference for the future basic and clinical translational research of lung cancer biomarkers.
摘要
肺癌是世界上发病率和死亡率最高的恶性肿瘤之一。目前，对早期诊断、治疗、预后和转移相关生物标志物的研究最为活跃。本文综述了肺癌标志物的研究现状，并分析了国内外近 10 年来肺癌标志物领域的资助情况，为肺癌标志物的未来基础和临床转化研究提供参考。
相似文献
1
Research status and funding trends of lung cancer biomarkers.肺癌生物标志物的研究现状与资金投入趋势。
J Thorac Dis. 2013 Oct;5(5):698-705. doi: 10.3978/j.issn.2072-1439.2013.10.10.
2
Clinical trials and biomarker research on lung cancer in China.中国肺癌的临床试验和生物标志物研究。
Expert Opin Ther Targets. 2012 Mar;16 Suppl 1:S45-50. doi: 10.1517/14728222.2011.630663. Epub 2012 Feb 7.
3
Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.对肺癌诊断、治疗及预后可能有用的生物标志物。
Biomed Pharmacother. 2007 Oct;61(9):515-9. doi: 10.1016/j.biopha.2007.08.005. Epub 2007 Sep 14.
4
[Mortality time trends and the incidence and mortality estimation and projection for lung cancer in China].[中国肺癌死亡率的时间趋势及发病率、死亡率估计与预测]
Zhongguo Fei Ai Za Zhi. 2005 Aug 20;8(4):274-8. doi: 10.3779/j.issn.1009-3419.2005.04.05.
5
The past, present and future of breast cancer research in China.中国乳腺癌研究的过去、现在和未来。
Cancer Lett. 2014 Aug 28;351(1):1-5. doi: 10.1016/j.canlet.2014.04.007. Epub 2014 Apr 13.
6
[Advanced research on circulating tumor cells in lung cancer].[肺癌循环肿瘤细胞的前沿研究]
Zhongguo Fei Ai Za Zhi. 2012 Nov;15(11):667-71. doi: 10.3779/j.issn.1009-3419.2012.11.03. Epub 2012 Oct 24.
7
Biomarkers in Lung Cancer.肺癌的生物标志物。
Clin Chest Med. 2020 Mar;41(1):115-127. doi: 10.1016/j.ccm.2019.10.004. Epub 2020 Jan 2.
8
Biological markers in lung cancer: A clinician's perspective.肺癌的生物学标志物：临床医生的视角。
Cancer Biomark. 2010;6(3-4):123-35. doi: 10.3233/CBM-2009-0124.
9
The State of Lung Cancer Research: A Global Analysis.肺癌研究现状：全球分析。
J Thorac Oncol. 2016 Jul;11(7):1040-50. doi: 10.1016/j.jtho.2016.03.010. Epub 2016 Mar 21.
10
Biomarkers for the lung cancer diagnosis and their advances in proteomics.肺癌诊断的生物标志物及其在蛋白质组学方面的进展。
BMB Rep. 2008 Sep 30;41(9):615-25. doi: 10.5483/bmbrep.2008.41.9.615.
引用本文的文献
1
Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer.苯并（a）芘诱导的癌症中DNA甲基化的动态变化
Genes Environ. 2023 Jul 1;45(1):21. doi: 10.1186/s41021-023-00278-1.
2
Physicochemical and Antioxidant Properties of the Degradations of Polysaccharides from and Their Suitable Molecular Weight Range on Inducing HeLa Cell Apoptosis.[某种物质]多糖降解产物的物理化学及抗氧化特性及其诱导HeLa细胞凋亡的适宜分子量范围
Evid Based Complement Alternat Med. 2019 Aug 28;2019:4127360. doi: 10.1155/2019/4127360. eCollection 2019.
3
Biosynthesis, characterization, and anticancer effect of plant-mediated silver nanoparticles using .利用. 合成、表征及植物介导的银纳米粒子的抗癌作用
Int J Nanomedicine. 2019 Mar 15;14:1969-1978. doi: 10.2147/IJN.S188235. eCollection 2019.
4
Jinfukang induces cellular apoptosis through activation of and in A549 cells.金复康通过激活A549细胞中的[具体物质1]和[具体物质2]诱导细胞凋亡。
Oncol Lett. 2018 Oct;16(4):4343-4352. doi: 10.3892/ol.2018.9149. Epub 2018 Jul 16.
5
microRNA-605 promotes cell proliferation, migration and invasion in non-small cell lung cancer by directly targeting LATS2.微小RNA-605通过直接靶向大肿瘤抑制因子2促进非小细胞肺癌的细胞增殖、迁移和侵袭。
Exp Ther Med. 2017 Jul;14(1):867-873. doi: 10.3892/etm.2017.4538. Epub 2017 Jun 1.
6
MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.微小RNA-107通过靶向脑源性神经营养因子介导的PI3K/AKT信号通路抑制人非小细胞肺癌的生长和转移。
Int J Oncol. 2016 Oct;49(4):1325-33. doi: 10.3892/ijo.2016.3628. Epub 2016 Jul 25.
7
Transcriptome Profiling Reveals the Antitumor Mechanism of Polysaccharide from Marine Algae Gracilariopsis lemaneiformis.转录组分析揭示龙须菜多糖的抗肿瘤机制
PLoS One. 2016 Jun 29;11(6):e0158279. doi: 10.1371/journal.pone.0158279. eCollection 2016.
8
Epigenetic Profiling of H3K4Me3 Reveals Herbal Medicine Jinfukang-Induced Epigenetic Alteration Is Involved in Anti-Lung Cancer Activity.H3K4Me3的表观遗传学分析揭示了中药金复康诱导的表观遗传改变参与抗肺癌活性。
Evid Based Complement Alternat Med. 2016;2016:7276161. doi: 10.1155/2016/7276161. Epub 2016 Mar 20.
9
Diagnostic value of serum glutathione peroxidase 3 levels in patients with lung cancer.血清谷胱甘肽过氧化物酶 3 水平对肺癌患者的诊断价值。
Thorac Cancer. 2014 Sep;5(5):425-30. doi: 10.1111/1759-7714.12113. Epub 2014 Aug 25.
10
Effect of edaravone on serum SP-A and arterial blood gas in patients with lobectomy.依达拉奉对肺叶切除患者血清表面活性蛋白A及动脉血气的影响
Int J Clin Exp Med. 2015 Jun 15;8(6):10021-5. eCollection 2015.
本文引用的文献
1
Crizotinib in the treatment of non--small-cell lung cancer.克唑替尼治疗非小细胞肺癌。
Clin Lung Cancer. 2013 Sep;14(5):473-80. doi: 10.1016/j.cllc.2013.04.006. Epub 2013 Jun 20.
2
Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer.早期非小细胞肺癌中七个基因的异常甲基化及其与临床特征的关联
Oncol Lett. 2013 Apr;5(4):1211-1218. doi: 10.3892/ol.2013.1161. Epub 2013 Jan 29.
3
Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.肺癌的早期检测、诊断和治疗预测的生物标志物和分子检测。
Thorac Surg Clin. 2013 May;23(2):211-24. doi: 10.1016/j.thorsurg.2013.01.002. Epub 2013 Feb 15.
4
Advances in cytopathology for lung cancer: the impact and challenges of new technologies.肺癌细胞病理学的进展：新技术的影响和挑战。
Thorac Surg Clin. 2013 May;23(2):163-78. doi: 10.1016/j.thorsurg.2013.01.011. Epub 2013 Feb 15.
5
Lung cancer in China: challenges and interventions.中国肺癌：挑战与干预。
Chest. 2013 Apr;143(4):1117-1126. doi: 10.1378/chest.11-2948.
6
Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.鉴定血浆 microRNAs 作为肺癌早期检测的新型无创生物标志物。
Eur J Cancer Prev. 2013 Nov;22(6):540-8. doi: 10.1097/CEJ.0b013e32835f3be9.
7
Selumetinib: a promising pharmacologic approach for KRAS-mutant advanced non-small-cell lung cancer.司美替尼：一种有前途的 KRAS 突变型晚期非小细胞肺癌的药物治疗方法。
Future Oncol. 2013 Feb;9(2):167-77. doi: 10.2217/fon.12.198.
8
Lung cancer epigenetics: emerging biomarkers.肺癌表观遗传学：新兴生物标志物。
Biomark Med. 2013 Feb;7(1):49-58. doi: 10.2217/bmm.12.111.
9
Lymph node micrometastases detected by carcinoembryonic antigen mRNA affect long-term survival and disease-free interval in early-stage lung cancer patients.通过癌胚抗原mRNA检测到的淋巴结微转移影响早期肺癌患者的长期生存和无病生存期。
Oncol Lett. 2012 Nov;4(5):1140-1144. doi: 10.3892/ol.2012.880. Epub 2012 Aug 24.
10
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.全基因组关联分析鉴定出亚洲从不吸烟女性肺癌的新易感基因位点。
Nat Genet. 2012 Dec;44(12):1330-5. doi: 10.1038/ng.2456. Epub 2012 Nov 11.
Zotero 插件